Literature DB >> 24635432

Second primary cancers -  causes, incidence and the future.

L Koubková, R Hrstka, P Dobes, B Vojtesek, R Vyzula.   

Abstract

Thanks to continually improving screening programs, diagnostic, and treatment methods, the survival rate in newly diagnosed cancer patients is increasing. With this improvement in survival, attention is now being focused on potential longterm complications such as multiple primary tumors, which represent a leading cause of late nonrelapse mortality. The number of patients who survive cancer dia-gnosis is growing by 2% each year. Multiple primary neoplasms have become the third most common finding in oncology since 1890s, when they were first described. This review aims to summarize recent information regarding the multiple primary neoplasms, elucidate the definition, etiology, association with the primary cancer treatment, genetic and environmental dispositions and finally, it recapitulates new approaches to identification of the risk factors for multiple cancers.

Entities:  

Mesh:

Year:  2014        PMID: 24635432     DOI: 10.14735/amko201411

Source DB:  PubMed          Journal:  Klin Onkol        ISSN: 0862-495X


  11 in total

1.  Molecular Identification and Genetic Characterization of Early-Stage Multiple Primary Lung Cancer by Large-Panel Next-Generation Sequencing Analysis.

Authors:  Guotian Pei; Mingwei Li; Xianjun Min; Qiang Liu; Dasheng Li; Yingshun Yang; Shuai Wang; Xiaoyu Wang; Huina Wang; Huanqing Cheng; Shanbo Cao; Yuqing Huang
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

2.  Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies.

Authors:  Shan Shan; Jun She; Zhi-Qiang Xue; Chun-Xia Su; Shen-Xiang Ren; Feng-Ying Wu
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

3.  Clinical Characteristics and Prognosis Associated with Multiple Primary Cancers in Breast Cancer Patients.

Authors:  Bong Kyun Kim; Se Jeong Oh; Jeong-Yoon Song; Han-Byoel Lee; Min Ho Park; Yongsik Jung; Woo-Chan Park; Jina Lee; Woo Young Sun
Journal:  J Breast Cancer       Date:  2018-03-23       Impact factor: 3.588

4.  Liver resection for hepatocellular carcinoma in patients with hematological malignancies.

Authors:  Hui-Chen Lin; Yang-Shen Yang; Chieh-Lin Jerry Teng; Ching-Hui Shen; Yee-Gee Jan; Shao-Bin Cheng; Cheng-Chung Wu; Yi-Ling Lin; Chu-Chun Huang; Fang-Ku P'eng
Journal:  World J Surg Oncol       Date:  2017-11-02       Impact factor: 2.754

5.  Metachronous triple primary neoplasms with primary prostate cancer, lung cancer, and colon cancer: A case report.

Authors:  Yuhua Feng; Meizuo Zhong; Shan Zeng; Desheng Xiao; Yiping Liu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

6.  Green tea extract for treatment of cancers: A systematic review protocol.

Authors:  Kai Cheng; Nan-Nan Chi; Jun-Dong Liu
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

7.  Metachronous Second Primary Malignancies in Known Breast Cancer Patients on 18F-Fluoro-2-Deoxyglucose Positron Emission Tomography-Computerized Tomography in a Tertiary Care Center.

Authors:  Ranadheer Gupta Manthri; Sai Moulika Jeepalem; V S Krishna Mohan; D Bhargavi; Narendra Hulikal; Tekchand Kalawat
Journal:  Indian J Nucl Med       Date:  2019 Oct-Dec

8.  Second primary malignancies in colorectal cancer patients.

Authors:  Jana Halamkova; Tomas Kazda; Lucie Pehalova; Roman Gonec; Sarka Kozakova; Lucia Bohovicova; Dagmar Adamkova Krakorova; Ondrej Slaby; Regina Demlova; Marek Svoboda; Igor Kiss
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

9.  Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up.

Authors:  Wei Xu; Wenjun Liao; Penglei Ge; Jinjun Ren; Haifeng Xu; Huayu Yang; Xinting Sang; Xin Lu; Yilei Mao
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

10.  Association of a novel point mutation in MSH2 gene with familial multiple primary cancers.

Authors:  Hai Hu; Hong Li; Feng Jiao; Ting Han; Meng Zhuo; Jiujie Cui; Yixue Li; Liwei Wang
Journal:  J Hematol Oncol       Date:  2017-10-03       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.